SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Report abuse about a comment

Further comment on dubious study

As I stated a week ago in response to the recently released study on resveratrol, the fault here is with the study design and protocol itself, not the resveratrol used in the study. The dosage used in this study was ridiculously low, compared to all earlier studies. In the case of the successful Albert Einstein Medical School study and the more recent Florida Pharmacology School study the dosages were approximately 10 to 20 times this amount. This dosage is consistent with the supplements used in those trials, specifically biotivia transmax and bioforte, which are readily available without a prescription. Using a dosage of only 75mg was tantamount to giving a heart attack victim one aspirin.

In all previous studies on actual type 2 diabetic patients or those suffering impaired glucose tolerance, a sign of impending diabetes, resveratrol was extremely effective in improving glucose tolerance, enhancing metabolic function and blocking the onset of diabetes.

As a cell biologist who has been involved in several human clinical trials of transmax and bioforte resveratrol against diabetes, I can only imagine that this study was designed by a pharmaceutical company to fail intentionally. The pharmas are clearly aware of the potential of resveratrol to cut into their sales of Metformin, a multi-billion dollar earner for the drug companies, and are on a campaign to discredit the compound.

As a researcher I question why the clinicians in this study would select as subjects women who have no issues with glucose tolerance, who were non-obese, and who did not exhibit signs of diabetes. This is equivalent to testing a compound designed to treat cancer on a group of subjects none of whom has cancer. Again, we see a troubling signal of possible pharma involvement.

Posted by James Betz
01 November 2012 | 08h40

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Resveratrol study results don’t tell the whole story on benefits: Expert

Spotlight

Equivocal study on Finnish women doesn't dim Vitamin D's role in lessening falls among elderly, experts say

Equivocal study on Finnish women doesn't dim Vitamin D's role in lessening falls among elderly, experts say

A new vitamin D/exercise study on falls among older women has confirmed the vitamin’s role in bone...

Goal for IPA to become more agile, vocal in promoting probiotics, new director says

Goal for IPA to become more agile, vocal in promoting probiotics, new director says

After a months-long interregnum, George Paraskevakos, the new executive director of the International Probiotics Association, formally takes up...

UNPA, AHPA move to ban sale of powdered caffeine among members

UNPA, AHPA move to ban sale of powdered caffeine among members

Trade organizations representing dietary supplement manufacturers have called on their members to cease the sale of bulk...

Neptune gets partly favorable krill oil patent ruling, but royalty payouts await appeal

Neptune gets partly favorable krill oil patent ruling, but royalty payouts await appeal

In what one side is billing as the final act in the krill wars in North America,...

Thorne extends sports nutrition efforts with EXOS partnership

Thorne extends sports nutrition efforts with EXOS partnership

Practioner channel specialist Thorne Research has taken another big step into the sports nutrition sphere with a...

Coalition recommends label declaration for use of nanotechnology

Coalition recommends label declaration for use of nanotechnology

A coalition of NGOs has released a policy recommendation on how companies should move forward on the...

Anti-depressant drug fluoxetine continuing to show up as adulterant in weight loss products

Anti-depressant drug fluoxetine continuing to show up as adulterant in weight loss products

There's another pharmaceutical ingredient to add to the list of APIs showing up in products marketed as...

Kyowa Hakko research underpins notion that cognitive decline now No.1 concern about aging

Kyowa Hakko research underpins notion that cognitive decline now No.1 concern about aging

New research commissioned by ingredient supplier Kyowa Hakko confirms what other recent surveys have shown: The specter...

Gaia Herbs: Our sales are growing as consumers move to a brand they trust

Gaia Herbs: Our sales are growing as consumers move to a brand they trust

Consumers are not turning their backs on herbal supplements in response to the NY AG’s probe, but...

DSM says nutrient education campaign can help quell confusion sown by NYAG affair

DSM says nutrient education campaign can help quell confusion sown by NYAG affair

The recent drop in the omega-3s market and the fallout from the New York Attorney General affair...